Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.
Karl J. Jorgenrud, President of Global Industrial at Sherwin-Williams (SHW), recently executed a cashless exercise of stock options and sold 7,886 shares, a move that trimmed his direct holdings while leaving sizable equity exposure.
See our latest analysis for Sherwin-Williams.
Sherwin-Williams' recent insider sale comes as the stock trades at US$359.10, with a 30-day share price return of 8.38% and a 90-day share price return of 18.60%, while the 1-year total shareholder return has edged down 0.75%. However, longer term total shareholder returns over three and five years remain positive.
If this kind of move has you looking beyond Sherwin-Williams, it could be a good time to broaden your watchlist with a screener of 21 top founder-led companies
So with Sherwin-Williams shares near US$359 and an insider trimming holdings but keeping significant exposure, do you add to a position now, or hold off and wait for a clearer margin of safety on valuation?
Most Popular Narrative: 7.9% Undervalued
Sherwin-Williams closed at $359.10, while the most widely followed narrative places fair value at $390.10, implying upside in that framework and a relatively tight valuation gap given the current analyst target range.
Sherwin-Williams is aggressively expanding its company-owned store footprint and field rep network, opening 80 to 100 new stores annually, despite current market softness. This positions the company to capture incremental revenue and market share as housing turnover and construction activity potentially improve alongside lower rates and better consumer confidence.
Want to see what drives that valuation gap for Sherwin-Williams? The narrative leans on steady revenue expansion, firmer margins, and a rich future earnings multiple. The detailed assumptions behind those projections might surprise you.
Result: Fair Value of $390.10 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Sherwin-Williams still faces softer housing demand and heavy fixed manufacturing costs, which could pressure margins if volumes or pricing assumptions fail to hold.
Find out about the key risks to this Sherwin-Williams narrative.
Another View on Sherwin-Williams Valuation
While the most popular narrative suggests Sherwin-Williams is 7.9% undervalued at around $359 versus a fair value of $390, the current P/E of 32.2x tells a different story. It sits above the US Chemicals industry at 27.8x, the peer average at 30.6x, and a fair ratio of 21.6x, which points to meaningful valuation risk if sentiment cools.
If you prefer to weigh P/E against what the market could move toward over time, it may be worth testing your own assumptions against our valuation breakdown. Then consider what would need to change in Sherwin-Williams' outlook for this premium to feel comfortable. See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With mixed signals around Sherwin-Williams valuation and insider activity, it makes sense to review the underlying data yourself and decide quickly where you stand. To weigh the balance of potential upside and the issues investors are watching, take a closer look at the 2 key rewards and 2 important warning signs .
Looking for more investment ideas beyond Sherwin-Williams?
If you are weighing your next move after reviewing Sherwin-Williams, do not sit on the sidelines while other opportunities pass by. Put fresh ideas on your radar.
-
Spot potential value ahead of the crowd by scanning screener containing 20 high quality undiscovered gems that many investors may be overlooking.
-
Prioritise balance sheet strength by checking companies in the solid balance sheet and fundamentals stocks screener (51 results) that can better handle tough conditions.
-
Lock in income-focused ideas by reviewing 10 dividend fortresses that could support a more reliable stream of cash returns.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SHW .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
